Global Antivenom Drugs Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Antivenom Drugs Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Antivenom drugs are used to treat venomous bites and stings, usually preferable in high-toxicity cases. Antivenin, venom antiserum, and antivenom immunoglobulin are the different other names of antivenom drugs. These medications can potentially reverse the effects of snake bites, and generally, an adequate therapeutic dose is injected. Additionally, these medications also help in kidney dialysis, artificial respiration, prosthesis as well as rehabilitation services.
Antivenom Drugs report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Antivenom Drugs market is projected to reach US$ 1384.7 million in 2029, increasing from US$ 1096 million in 2022, with the CAGR of 3.4% during the period of 2024 to 2029. Demand from Hospital and Clinical Laboratory are the major drivers for the industry.
There are more than 3,000 species of snakes in the world, of which about 250 are prioritized by the WHO because of the potential for serious injury from their venom, spread across 160 countries around the world, the WHO said. Snakebites mainly occur in developing countries in tropical and subtropical regions. Sub-Saharan Africa, tropical Asia, New Guinea, and central and southern America are all high incidence areas of snakebite. In India alone, as many as 2.8 million people are bitten by snakes every year, and more than 46,000 of them die. Rising number of people bitten by snakes is the key driver for the growth of the antivenom market.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Antivenom Drugs market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
Bioclone Institute
Pfizer Inc
Merck KGaA
VINS Bioproducts Ltd
BTG International Inc
Incepta Pharma
Bharat Serums and Vaccines Limited
Boston Scientific Corporation
Alomone Labs
Wyeth, LLC
Serum Biotech
Segment by Type
Monovalent
Polyvalent
Hospital
Clinical Laboratory
Field Rescue Station
Other
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Antivenom Drugs market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Antivenom Drugs, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Antivenom Drugs industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Antivenom Drugs in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Antivenom Drugs introduction, etc. Antivenom Drugs Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Antivenom Drugs market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Antivenom Drugs report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Antivenom Drugs market is projected to reach US$ 1384.7 million in 2029, increasing from US$ 1096 million in 2022, with the CAGR of 3.4% during the period of 2024 to 2029. Demand from Hospital and Clinical Laboratory are the major drivers for the industry.
There are more than 3,000 species of snakes in the world, of which about 250 are prioritized by the WHO because of the potential for serious injury from their venom, spread across 160 countries around the world, the WHO said. Snakebites mainly occur in developing countries in tropical and subtropical regions. Sub-Saharan Africa, tropical Asia, New Guinea, and central and southern America are all high incidence areas of snakebite. In India alone, as many as 2.8 million people are bitten by snakes every year, and more than 46,000 of them die. Rising number of people bitten by snakes is the key driver for the growth of the antivenom market.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Antivenom Drugs market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Bioclone Institute
Pfizer Inc
Merck KGaA
VINS Bioproducts Ltd
BTG International Inc
Incepta Pharma
Bharat Serums and Vaccines Limited
Boston Scientific Corporation
Alomone Labs
Wyeth, LLC
Serum Biotech
Segment by Type
Monovalent
Polyvalent
Segment by Application
Hospital
Clinical Laboratory
Field Rescue Station
Other
Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Antivenom Drugs market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Antivenom Drugs, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Antivenom Drugs industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Antivenom Drugs in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Antivenom Drugs introduction, etc. Antivenom Drugs Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Antivenom Drugs market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices